Drug Trial Radar · NCT01914757
Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist
Last checked: Nov 20, 2026Latest source record: Jan 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,508
Actual
Start
Aug 2013
Primary completion
Mar 2016
Study completion Mar 2016
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 2, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Benralizumab reduces the exacerbation rate in patients with a history of asthma exacerbations and uncontrolled asthma receiving ICS-LABA with or without oral corticosteroids and additional asthma controllers.
Conditions
- Asthma
Interventions
BenralizumabBiological
Benralizumab subcutaneously on study week 0 until study week 52 inclusive.
PlaceboBiological
Placebo subcutaneously on study week 0 until study week 52 inclusive.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annual Asthma Exacerbation Rate in Adult and Adolescent Patients With Uncontrolled Asthma for Patients With Baseline Eosinophils >=300/uLTime frame: Immediately following the first administration of study drug through Study Week 56.
Locations
214 sites in 11 countries. Site status is shown where the registry gives one.
Research Site
Andalusia, Alabama
Research Site
Birmingham, Alabama
Research Site
Flagstaff, Arizona
Research Site
Glendale, Arizona
Research Site
Phoenix, Arizona
Research Site
Tucson, Arizona
Research Site
Alhambra, California
Research Site
Anaheim, California
Research Site
Beverly Hills, California
Research Site
Garden Grove, California
Research Site
Lakewood, California
Research Site
North Hollywood, California
Research Site
Northridge, California
Research Site
Palmdale, California
Research Site
Rancho Mirage, California
Research Site
Redondo Beach, California
Research Site
Rolling Hills Estate, California
Research Site
Sacramento, California
Research Site
Stockton, California
Research Site
Thousand Oaks, California
Research Site
Upland, California
Research Site
Ventura, California
Research Site
Walnut Creek, California
Research Site
Westminster, California
Research Site
Woodland, California
Research Site
Centennial, Colorado
Research Site
Colorado Springs, Colorado
Research Site
Wheat Ridge, Colorado
Research Site
Celebration, Florida
Research Site
Fort Lauderdale, Florida
Research Site
Hialeah, Florida
Research Site
Homestead, Florida
Research Site
Jacksonville, Florida
Research Site
Lehigh Acres, Florida
Research Site
Miami, Florida
Research Site
Ocala, Florida
Research Site
Orlando, Florida
Research Site
Ormond Beach, Florida
Research Site
Virginia Gardens, Florida
Research Site
Gainesville, Georgia
Showing 40 of 214 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.